(9-357) Efficacy of 3 Mg vs 4.5 Mg of Rasburicase on Uric Acid Reduction in Tumor Lysis Syndrome

Wednesday, December 7, 2022

8:30 AM – 9:30 AM

Location: Bayside A, Level 1

Category: Research-in-Progress
Topic: Oncology/Hematology

Co-Author(s): Samantha Buhrow, Marcus Silva, Jodi Weiksnar

Primary Author(s)

Caroline E. Scronce, PharmD
Primary Author
Cleveland Clinic Martin Health, Florida